LISDEXAMFETAMINE 30 MG CAPSULE

Lisdexamfetamine dimesylate
$3.0486per EA
DEA Schedule CII

Strength

30 mg/1

NDC

00480356701

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Last Updated

4/22/2026

Active Ingredients

LISDEXAMFETAMINE DIMESYLATE

Approval Type

Generic (ANDA)

FDA Application

ANDA202802

On Market Since

12/17/2024

Pharmacological Classes

Central Nervous System Stimulant
Central Nervous System Stimulation

Price History

1W

0.0%

1M

+3.0%

3M

-4.2%

6M

-11.9%

1Y

-28.0%

3Y

N/A

5Y

N/A

All

-37.6%